返回 Agenda
Session 7: Disease Awareness Campaigns - Best Practices and What to Avoid
Session Chair(s)
Nicol George, PharmD, RPh
Executive Vice President, Promotional Review & Labeling Services
ProPharma Group, United States
Disease awareness campaigns are essential for informing healthcare professionals (HCPs) and patients. These campaigns highlight disease signs and symptoms, reduce stigma, and encourage proactive health management, enabling timely medical advice. For HCPs, they open dialogue with patients, promote health screenings, and share new insights, especially for rare diseases. This session explores best practices from pre-launch to post-launch, covering media, social channels, and HCP influencer safeguards, focusing on disease education without crossing into treatment promotion.
Learning Objective : - Discuss best practice recommendations to use disease awareness campaigns leading into anticipated drug approval
- Identify disease awareness education for HCPs and patients versus implied or expressed treatment claims to ensure compliance
- Analyze real-world examples of successful disease awareness HCP Influencer campaigns
Speaker(s)
Disease Awareness Campaigns: A Regulatory Perspective
Kevin Hollister, MBA, MPH, MS
Alexion, United States
Head of Advertising and Promotional Compliance
Disease Awareness Campaigns Through an HCP Lens
Adam Goodcoff, DO
MedFluencers, United States
Chief Executive Officer and Co-Founder
DSA in Social Media
Joshua Simon, MBA
CMI Media Group, United States
SVP, Social Center of Excellence